Back to Journals » International Journal of Nanomedicine » Volume 13

Non-ionic thiolated cyclodextrins — the next generation

Authors Moghadam A, Ijaz M, Asim MH, Mahmood A, Jelkmann M, Matuszczak B, Bernkop-Schnürch A

Received 4 October 2017

Accepted for publication 12 May 2018

Published 10 July 2018 Volume 2018:13 Pages 4003—4013

DOI https://doi.org/10.2147/IJN.S153226

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Govarthanan Muthusamy

Peer reviewer comments 2

Editor who approved publication: Dr Thomas Webster


Ali Moghadam,1,2 Muhammad Ijaz,2,3 Mulazim Hussain Asim,2,4 Arshad Mahmood,2,5 Max Jelkmann,2 Barbara Matuszczak,6 Andreas Bernkop-Schnürch2

1Institute of Biotechnology, College of Agriculture, Shiraz University, Shiraz, Iran; 2Center for Chemistry and Biomedicine, Department of Pharmaceutical Technology, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria; 3Department of Pharmacy, COMSATS Institute of Information and Technology, Lahore, Pakistan; 4Department of Pharmaceutics, Faculty of Pharmacy, University of Sargodha, Sargodha, Pakistan; 5Department of Pharmacy, COMSATS Institute of Information Technology Abbottabad, Pakistan; 6Center for Chemistry and Biomedicine, Department of Pharmaceutical Chemistry, Institute of Pharmacy, University of Innsbruck, Innsbruck, Austria

Introduction:
The current study was aimed at developing a novel mucoadhesive thiolated cyclodextrin (CD) without ionizable groups and an intact ring backbone for drug delivery.
Materials and methods: Thiolated beta CD (β-CD) was prepared through bromine substitution of its hydroxyl groups followed by replacement to thiol groups using thiourea. The thiolated β-CD was characterized in vitro via dissolution studies, cytotoxicity studies, mucoadhesion studies on freshly excised porcine intestinal mucosa, and inclusion complex formation with miconazole nitrate.
Results: Thiolated β-CDs namely β-CD-SH600 and β-CD-SH1200 displayed 558.66 ± 78 and 1,163.45 ± 96 µmol thiol groups per gram of polymer, respectively. Stability constant (Kc) of 190 M-1 confirmed the inclusion complex formation of miconazole nitrate with β-CD-SH. Inclusion complexes of β-CD-SH600 and β-CD-SH1200 resulted in 157- and 257-fold increased solubility of miconazole nitrate, respectively. In addition, more than 80% of thiol groups were stable even after 6 hours at pH 5. Both β-CD-SH compounds showed at least 1.3-fold improved solubility in water. In contrast to cationic thiolated CDs of the first generation, both thiomers showed no significant cytotoxicity. The mucoadhesive properties of the new thiolated CDs were 39.73- and 46.37-fold improved, respectively.
Conclusion: These results indicate that β-CD-SH might provide a new favorable tool for delivery of poorly soluble drugs providing a prolonged residence time on mucosal surfaces.

Keywords: thiolated cyclodextrin, mucosal delivery, inclusion complex

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]